A Scan Ultrasonography in the Evaluation of Retinopathy of Prematurity

July 7, 2020 updated by: Darius M. Moshfeghi, Stanford University
The purpose of the investigators study is to determine the relationship between the length of the eye and the rate of change in eye length at each visit with progression of retinopathy of prematurity.

Study Overview

Status

Terminated

Study Type

Observational

Enrollment (Actual)

1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Florida
      • Miami, Florida, United States, 33136
        • University of Miami

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Premature newborns who are screened for retinopathy of prematurity at Stanford

Description

Inclusion Criteria:

  • neonates being screened for retinopathy of prematurity

Exclusion Criteria:

  • medically unstable neonates

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
axial length
Time Frame: one year
axial length as measured by a scan ulstrasonography
one year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
anterior corneal curvature
Time Frame: one year
anterior corneal curvature as measured by keratometer
one year
wide angle fundus photography
Time Frame: one year
wide angle fundus photography by RetCam camera
one year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Darius Moshfeghi, MD, Stanford University
  • Study Director: Darius M Moshfeghi, MD, Stanford University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2010

Primary Completion (Actual)

October 1, 2015

Study Completion (Actual)

October 1, 2015

Study Registration Dates

First Submitted

April 1, 2011

First Submitted That Met QC Criteria

April 12, 2011

First Posted (Estimate)

April 14, 2011

Study Record Updates

Last Update Posted (Actual)

July 9, 2020

Last Update Submitted That Met QC Criteria

July 7, 2020

Last Verified

July 1, 2020

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Retinopathy of Prematurity

3
Subscribe